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Abstract
Background: Evidence indicates that hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the leading
causes of liver cirrhosis and hepatocellular carcinoma. Antiviral treatments have recently been reported as successful
cures. However, the prevalence rates of HBV or HCV infection, unhealthy behaviors and receipt of adequate treatment in
disabled adults have not been described. The aim of this study was to examine the prevalence of HBV or HCV carriers,
receipt of antiviral treatment, and early detection of unhealthy behaviors in disabled adults in Taiwan.
Methods: A population-based, cross-sectional study was conducted between July and December 2013 with 845
community-dwelling adults with disabilities aged >20 years. Statistical analyses included descriptive statistics,
Chi-squared tests, and stepwise regression analysis.
Results: The prevalence of HBV and HCV infections was 12.9 and 14.1 %, respectively. HCV carriers tended to be
older (p < 0.001) and with a lower education (p < 0.001). The majority of HBV/HCV carriers did not know the type
of hepatitis infection and did not receive adequate antiviral treatment. After adjusting for potential confounding
variables, regression analysis showed that the factors significantly associated with elevated liver function were HCV
infection (p < 0.001), HBV infection (p = 0.001), high fasting blood glucose levels (p = 0.001), overweight (p = 0.003), older
age (p = 0.027), and alcohol drinking (p = 0.028).
Conclusions: There was a high prevalence of HCV infection among adults with disabilities; few received adequate
antiviral treatment or early detection of unhealthy behaviors for the prevention of liver cancer. Clinicians can provide
health education to help the participants and caregivers better understand the relationships between specific risk
factors and liver health and can encourage HBV and HCV carriers to undergo annual physical check-ups and receive
adequate treatment, as covered by the national health insurance.
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Background
Liver cancer is one of the most common cancers world-
wide, particularly in Central and East Asia [1]. The leading
causes of liver cirrhosis, liver failure, and hepatocellular
carcinoma (HCC) are hepatitis B virus (HBV) and hepa-
titis C virus (HCV) infections. Hepatitis is inflammation
of the liver, most commonly caused by a viral infection
[1–4]. The mechanism by which hepatitis viral infection
leads to liver cancer might involve the infection-related
chronic inflammation [3, 4].
Globally, HBV and HCV infections and their sequelae
remain a major health problem, associated with 1.45
million deaths annually [5]. In Taiwan, liver cirrhosis
and HCC are the most common causes of death, ac-
counting for 34.9 deaths per 100,000 persons [6]. In
addition, HBV and HCV are endemic, with prevalence
rates of 15–20 and 2–3 %, respectively, among the
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general adult population. An estimated 2.5–3.0 million
people are HBV carriers, and nearly 90 % of HCC pa-
tients are infected with HBV or HCV. Furthermore,
60–90 % of carriers are at risk of liver cirrhosis and
HCC [6, 7]. In Taiwan, HCV infection is significantly
associated with health disparity and older people in dis-
advantaged areas [8–10].
HBV infection occurs mainly during early childhood,
and mother-to-infant transmission accounts for the ma-
jority of cases with chronic infection [3]. The majority of
HCV infections are transmitted via contact with the
blood of an infected person or with unsterilized mate-
rials, such as injectable drug equipment, razors, or tattoo
needles [4]. Fortunately, Taiwan launched a universal
HBV vaccination program in 1984, in which three HBV
vaccine doses were administered to all infants starting
from the first week of life [3]. Long-term studies have
demonstrated that 20 years after the mass HBV vaccin-
ation program was implemented, the incidence of HBV
infection significantly declined to 0.6 % in young adults
[11, 12]. Additionally, antiviral treatments for HBV and
HCV in adult carriers, such as interferon combined with
ribavirin, have recently been reported as successful cures
[1–4]. However, many people still receive inadequate
treatment, especially disabled residents living in rural
areas [10].
In Taiwan, more than one million people were desig-
nated as disabled by the government in 2012 [13]. The
top five disabilities were physical disability, loss of vital
organs, hearing impairment, intellectual disability, and a
combination of disabilities. People with disabilities have
poorer health outcomes, less education, less economic
participation, and higher rates of poverty than people
without disabilities [14]. Therefore, disability has become
a human rights issue in Taiwan; the potential health care
savings due to early intervention and prevention efforts
have also recently been recognized [13].
Liver dysfunction, such as abnormal serum glutamate-
pyruvate transaminase (SGPT) levels, and HCC have
been associated not only with HBV or HCV infection
but also with cigarette smoking, alcohol drinking, and
obesity [10, 15–18]. In addition, obesity is an increas-
ingly important health problem in disabled people [19].
Therefore, reductions in weight might reverse the bur-
den of liver function; strategies for weight loss include
adopting a healthier diet (e.g., 3 servings of vegetables
and 2 servings of fruit daily), drinking plenty of water
(e.g., 1500 mL/day), and exercising (e.g., 30 min/day, 3
times per week) [20].
Few actions have been implemented to enhance cancer
prevention policies among HBV or HCV carriers in dis-
advantaged areas. Moreover, few studies have explored
the prevalence of and relationships with unhealthy be-
haviors, health status, and receipt of adequate treatment
among disabled HBV or HCV carriers. In this study, we
investigated the prevalence of and relationships between
unhealthy behaviors and determinants of liver function
among disabled HBV/HCV carriers.
Methods
Participants and design
This study was part of a health promotion program for
community-dwelling adults with disabilities led by a
nursing team in collaboration with a private hospital and
the Bureau of Health Promotion in Chiayi County,
Taiwan. This cross-sectional, descriptive study aimed to
explore the prevalence of HBV/HCV carriers and receipt
of anti-viral treatment in the southwestern coastal area.
In this area, there were 37,629 people with disabilities,
based on government records [13]; from these records,
participants were selected by convenience sampling. The
inclusion criteria were the ability to (1) complete the
questionnaire in writing or by interview in Mandarin or
Taiwanese with or without assistance or via a caregiver,
(2) walk or transfer to the local hospital with or without
assistance from family or institutional staff, and (3) pro-
vide written informed consent before study enrollment.
Participants who were unable to answer questions, who
had severe chronic disease or cancer, or who were
undergoing dialysis were excluded.
A community-based health screening survey was con-
ducted between July and December 2013, and 1024 dis-
abled residents participated in this project. From this
information, we determined the prevalence rates of viral
infections, receipt of adequate antiviral treatments, un-
healthy behaviors, and risk factors associated with liver
function among disabled HBV/HCV carriers.
Instruments and measurements
A. Demographic characteristics included age, gender,
education level (years of education achieved), marital
status, occupation, living arrangement, and disability
classification. Disabilities were classified according to
the government definition (e.g., physical, intellectual,
and multiple disabilities) and confirmed before the
interview was conducted.
B. Unhealthy behaviors and receipt of anti-virus treatment
were assessed based on expert recommendations
related to adopting healthy lifestyles and habits for
the liver [10, 20] using eight questions (1) “Do you
regularly drink alcohol?” Drinking was classified as
“never” if the participant had never consumed
alcohol, “ceased” if the participant had previously
consumed alcohol but had ceased drinking alcohol
for at least 6 months, or “current” if the participant
was currently drinking. (2) “Do you smoke
cigarettes?” Smoking was classified as “never”
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if the participant never smoked, “ceased” if the
participant had previously smoked but had ceased
smoking for at least 6 months, or “current” if the
participant was currently smoking. (3) Regular
exercise was classified as “irregular” if the participant
responded never or sometimes or as “regular”
if the participant usually exercised for a total or
cumulative duration of >30 min per day, three times
per week, or 150 min per week. (4) “How often do
you consume at least 1500 mL or eight bowl-sized
cups of water each day?” The answer was classified
as “insufficient” if the participant answered never
or sometimes and as “sufficient” if the participant
answered usually or always. (5) “Do you eat 3
servings of vegetables every day?” The answer was
classified as “insufficient” if the participant answered
never or sometimes and as “sufficient” if the
participant usually consumed at least 3 servings
or 1.5 bowl-sized servings of vegetables per day.
(6) “Do you eat 2 servings of fruit every day?” The
answer was classified as “insufficient” if the participant
answered never or sometimes and as “sufficient” if the
participant usually consumed at least 2 servings or
one bowl-sized serving of fruit per day. (7) “Do you
know that you have a viral infection called hepatitis?”
If yes, then the participant was asked (8) “Have you
received hepatitis treatment, such as an anti-viral
prescription from a physician?”
C. Physiological biomarkers were measured for liver
function, including HBV, HCV, and SGPT
(normal range, <40 mU/mL) as measured by the
collaborating hospital during the physical
examination and serum hepatitis B surface antigen
(HBsAg) and anti-HCV antibodies as determined
using enzyme-linked immunoassays; fasting blood
glucose (normal range, <110 mg/dL); systolic
and diastolic blood pressure (normal range,
<140/90 mmHg); and body mass index (BMI),
as calculated by weight (kg) divided by the square
of height (m2). All standard references were from
the Ministry of Health and Welfare [21].
Procedure and ethical considerations
This study was approved by the Ethical Committee of
the Institutional Review Board (Chang Gung Memorial
Hospital No 102-3331B). Written informed consent was
obtained from all participants or their caregiver, after
describing the study purpose and explaining that a free
medical examination would be provided. A cover letter
inviting participation in the study was sent to the 18
district public health nurses; this letter emphasized that
the responses would remain confidential. Participants
were allowed to ask questions and seek clarification
about the study before they consented to participate. All
participants were interviewed during a weekend in a
school auditorium after the blood collection and physical
examination by the staff of the collaborating hospital. To
help build a caring environment, each participant was
accompanied by a senior nursing student and commu-
nity volunteer during the health screenings.
Data analysis
SPSS version 20 (IBM Corp., Armonk, NY) was used for
data analyses. All tests were two-sided, and p values <0.05
were considered statistically significant. The Chi-square
statistic for testing the equality of proportions or rates was
used to compare demographic variables, physiological bio-
markers, and unhealthy behaviors between the individuals
with or without HBV or HCV infection. Multivariate
linear regression was used to analyze the factors associ-
ated with liver function that were chosen on the basis
of relevant confounders after univariate analysis.
Results
Demographic characteristics
Of the 1024 disabled community residents who were
eligible, 177 did not meet the inclusion criteria, resulting
in 847 participants for data analyses. After excluding 1
participant who failed to complete the physical examin-
ation and 1 participant who had an incomplete question-
naire, the final data analyses were conducted with 845
participants. The mean age was 53.9 years (SD = 18.4;
range 20–96), and the majority of the participants were
men (n = 472, 55.8 %). Nearly one-third of the participants
(n = 276, 32.6 %) had a physical disability, 27 % (n = 227)
had an intellectual disability, and the remainder (n = 342,
40.4 %) had multiple disabilities. Nearly half (50.8 %) did
not have an education beyond middle school. More than
two-thirds of the participants were unemployed (n = 609),
49 % were married, and more than two-thirds (78.9 %)
were living with their family, while the remainder lived
with health care assistants or alone (Table 1).
The prevalence of HBV and HCV infections was
12.9 % (n = 109) and 14.1 % (n = 119), respectively
(Table 1). Based on HBV infection, there were no statis-
tically significant differences in gender, disability classifi-
cation, education level, occupation status, and living
arrangement; however, age and marital status were sig-
nificantly different. Based on HCV infection, there were
no significant differences in gender and living arrange-
ment; however, the HCV carriers tended to be older
(χ2 = 24.6, p < 0.001) and have a lower level of educa-
tion (χ2 = 16.4, p < 0.001) than the non-carriers.
Unhealthy behaviors between hepatitis B or C
virus carriers
Of the total sample, 77 (9.1 %) and 121 (14.3 %) partici-
pants were current users of alcohol and cigarette smokers,
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respectively. More than half (53.5 %, n = 452) reported
irregular exercise, 66.7 % (n = 563) reported insufficient
water intake, 81 % (n = 685) reported insufficient fruit in-
take, and 67.5 % (n = 570) reported insufficient vegetable
intake. There were no significant differences between
HBV/HCV carriers and non-carriers in any of the health-
related behaviors (Table 2). Regarding knowledge of hepa-
titis viral infection, the majority of HBV/HCV carriers did
not know the type of hepatitis infection and had not
received adequate anti-viral treatment (p < 0.001, Table 2).
Physiological biomarkers and health status among
hepatitis carriers
HCV carriers tended to have abnormal SGPT (χ2 =
53.72, p < 0.001) and systolic blood pressure (χ2 = 6.29,
p < 0.05) levels (Table 3). Considering the health status
of the HBV and HCV carriers, 49.5 and 58.7 % were
overweight, respectively; 28.7 and 44.9 % had abnormal
systolic blood pressure, respectively; and 18.3 and
26.9 % had high fasting blood glucose, respectively.
After adjusting for potential confounding variables, HCV
infection (β = 0.2, p < 0.001), HBV infection (β = 0.12,
p = 0.001), high fasting blood glucose levels (β = 0.11,
p = 0.001), overweight (β = 0.1, p = 0.003), older age
(β = −0.08, p = 0.027), and current alcohol drinking
(β = 0.08, p = 0.028) were significant in the regression
analysis for elevated liver function (Table 4).
Discussion
Despite the limitations of the present study, including
the convenience sampling that limits the generalizability
of the findings to all adults with disabilities in Taiwan,
four key findings regarding liver health in disabled adult
Table 1 Demographic characteristics of the samples (N = 845)
Variables Hepatitis B infection Hepatitis C infection
Negative Positive Negative Positive
N (%) N (%)
Gender χ2 = 2.16 χ2 = 0.01
Female 332 (89.0) 41 (11.0) 320 (85.8) 53 (14.2)
Male 404 (85.5) 68 (14.4) 406 (86.0) 66 (14.0)
Age (years)
Mean ± SD
51.5 ± 14.7 χ2 = 11.76** 62.5 ± 15.7 χ2 = 24.63***
~ 39 184 (87.2) 27 (12.8) 198 (93.8) 13 (6.2)
40 ~ 64 307 (83.2) 62 (16.8) 321 (87.0) 48 (13.0)
≥ 65 245 (92.5) 20 (7.5) 207 (78.1) 58 (21.9)a
Disability classification χ2 = 1.21 χ2 = 7.16*
Physical 243 (88.0) 33 (12.0) 231 (83.7) 45 (16.3)
Intellectual 193 (85.0) 34 (15.0) 207 (91.2) 20 (8.8)
Multiple disabilities 300 (87.7) 42 (12.3) 288 (84.2) 54 (15.8)
Education χ2 = 0.84 χ2 = 16.36***
≤ Primary school 378 (88.1) 51 (11.9) 348 (81.1) 81 (18.9)
≥Middle school 356 (86.0) 58 (14.0) 376 (90.8) 38 (9.2)
Occupation χ2 = 0.11 χ2 = 5.09*
With job 207 (87.7) 29 (12.3) 213 (90.3) 23 (9.7)
Without job 529 (86.9) 80 (13.1) 513 (84.2) 96 (15.8)
Marital statusa χ2 = 6.48* χ2 = 13.56***
Single 269 (85.4) 46 (14.6) 288 (91.4) 27 (8.6)
Married 371 (89.8) 42 (10.2) 344 (83.3) 69 (16.7)
Others 94 (81.7) 21 (18.3) 92 (80.0) 23 (20.0)
Living arrangement χ2 = 0.06 χ2 = 0.22
With families 580 (87.0) 87 (13.0) 575 (86.2) 92 (13.8)
Other 156 (87.6) 22 (12.4) 151 (84.8) 27 (15.2)
Pearson Chi-Square: *p < 0.05; **p < 0.01; ***p < 0.001
awith missing data
Table 2 Health-related behaviors among hepatitis B or C virus
carriers
Variables Hepatitis B infection Hepatitis C infection
Negative Positive Negative Positive
N (%) N (%)
Alcohol usea χ2 = 4.88 χ2 = 0.41
Never 625 (85.1) 85 (78.0) 608 (84.0) 102 (85.7)
Current user 61 (8.3) 16 (14.7) 68 (9.4) 9 (7.6)
Cessation 48 (6.5) 8 (7.3) 48 (6.6) 8 (6.7)
Cigarette smoke χ2 = 3.56 χ2 = 0.43
Never 555 (75.4) 75 (68.8) 544 (74.9) 86 (72.3)
Current smokers 99 (13.5) 22 (20.2) 103 (14.2) 18 (15.1)
Cessation 82 (11.1) 12 (11.0) 79 (10.9) 15 (12.6)
Adopting regular exercisea χ2 = 1.86 χ2 = 0.40
Irregular 387 (52.7) 65 (59.6) 392 (54.0) 60 (50.8)
Regular 348 (47.3) 44 (40.4) 334 (46.0) 58 (49.2)
Water (1500 mL/day)a χ2 = 0.21 χ2 = 0.26
Sufficient 245 (33.4) 34 (31.2) 242 (33.5) 37 (31.1)
Insufficient 488 (66.6) 75 (68.8) 481 (66.5) 82 (68.9)
Fruit (2 servings/day) χ2 = 0.01 χ2 = 0.77
Sufficient 139 (18.9) 21 (19.3) 134 (18.5) 26 (21.8)
Insufficient 597 (81.1) 88 (80.7) 592 (81.5) 93 (78.2)
Vegetable (3 servings/day) χ2 = 0.01 χ2 = 0.02
Sufficient 239 (32.5) 36 (33.0) 237 (32.6) 38 (31.9)
Insufficient 497 (67.5) 73 (67.0) 489 (67.4) 81 (68.1)
Awareness of viral infection χ2 = 44.7*** χ2 = 49.97***
Yes 26 (3.5) 21 (19.3) 24 (3.3) 23 (19.3)
No 710 (96.5) 88 (80.7) 702 (96.7) 96 (80.7)
Receiving antiviral treatment χ2 = 21.31*** χ2 = 30.56***
Yes 12 (1.6) 10 (9.2) 10 (1.4) 12 (10.1)
No 724 (98.4) 99 (90.8) 716 (98.6) 107 (89.9)
***p < 0.001
awith missing data
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HBV or HCV carriers emerged from this study. First,
there was a high prevalence of HCV infection in adults
with disabilities, especially in older people and those
with a low socioeconomic status. Second, few people are
aware of viral infections, and very few receive antiviral
treatment, which are effective and can successfully cure
the infection. Third, most of the disabled participants
with or without hepatitis reported some specific unhealthy
behaviors. Fourth, high fasting blood glucose levels, over-
weight, and alcohol consumption were important and
preventable risk factors, in addition to HBV/HCV infec-
tion and older age.
The prevalence rate of HBV in the present study
(12.9 %) was lower than the nationwide prevalence
(15–20 %), but higher than those of the adult popula-
tion in different geographical areas, including sub-
Saharan Africa and East Asia (5–10 %), the Middle East
(2–5 %), and Western Europe and North America (1 %)
[1–4]. Therefore, although the number of newly acquired
HBV infections in Taiwan has declined substantially since
the implementation of the national immunization pro-
gram, the prevalence of chronic HBV and HCV infections
remains high in some rural areas [3, 10, 12], including the
western coastal areas (HBV, 18.7 %; HCV, 20.8 %) [10].
Based on the results of the present study (Table 2),
possible reasons for higher rates of HCV infection in
adults with disabilities living in rural areas (14.1 %) than
the nationwide prevalence (2–3 %) include health dispar-
ity resulting from the limited resources and unqualified
medical personnel using unsterilized materials [4], lack
of education, poverty, illiteracy, and lack of information
about virus-related hepatitis. Although there is currently
no vaccine for HCV, evidence strongly suggests that
some antiviral drugs are effective for eradicating the en-
tire virus and reducing the incidences of hepatic cancer
by 78 % and liver cirrhosis by 47 % [1–4]. Fortunately,
antiviral treatments, such as interferon, lamivudine, ade-
fovir, and ribavirin are covered by the Taiwan national
health insurance [4]. Therefore, strategies to enhance
the awareness of virus infection and motivate disabled
residents to receive and complete the entire course of
antiviral treatments are important issues for clinicians
and primary health care providers.
The present study also revealed that many disabled par-
ticipants have unhealthy behaviors, such as inadequate
exercise and insufficient water, fruit, and vegetable intake.
Table 3 Physiological biomarkers associated with hepatitis B or
C virus carriers
Variables Hepatitis B infection Hepatitis C infection
Negative Positive Negative Positive
N (%) N (%)
SGPT (mu/mL) χ2 = 1.66 χ2 = 53.72***
< 40 635 (86.3) 89 (81.7) 648 (89.3) 76 (63.9)
≥ 40 101 (13.7) 20 (18.3) 78 (10.7) 43 (36.1)
Body mass index (kg/m2) χ2 = 1.87 χ2 = 0.38
Average/under 292 (43.2) 50 (50.5) 299 (44.6) 43 (41.3)
Overweight/Obesity 384 (56.8) 49 (49.5) 372 (55.4) 61 (58.7)
SBP (mmHg) χ2 = 1.98 χ2 = 6.29*
< 140 470 (64.4) 77 (71.3) 482 (66.9) 65 (55.1)
≥ 140 260 (35.6) 31 (28.7) 238 (33.1) 53 (44.9)
DBP (mmHg) χ2 = 0.54 χ2 = 0.03
< 90 558 (76.4) 86 (79.6) 554 (76.9) 90 (76.3)
≥ 90 172 (23.6) 22 (20.4) 166 (23.1) 28 (23.7)
FBG (mg/dL) χ2 = 0.66 χ2 = 2.56
< 109 575 (78.2) 89 (81.7) 577 (79.6) 87 (73.1)
≥ 110 160 (21.8) 20 (18.3) 148 (20.4) 32 (26.9)
Abbreviations: SGPT serum glutamic pyruvic transaminase, SBP systolic blood
pressure, DBP diastolic blood pressure, FBG fasting blood glucose
*p < 0.05; ***p < 0.001
Table 4 Factors associated with elevated liver function (SGPT)
Variables Unstandardized Beta t value p 95 % CIa
B SE
Constant 19.85 1.67 11.89 <0.001 16.58 ~ 23.13
HCV (1 = positive) 15.28 2.59 0.20 5.90 <0.001 10.19 ~ 20.37
HBV (1 = positive) 9.30 2.68 0.12 3.47 0.001 4.04 ~ 14.56
Fasting blood glucose
(1 > 110 mg)
7.26 2.24 0.11 3.25 0.001 2.87 ~ 11.65
BMI (1 = overweight/obesity) 5.71 1.89 0.10 3.02 0.003 2.00 ~ 9.42
Age (1 > 65) −4.40 1.98 −0.08 −2.22 0.027 −8.29 ~ −0.51
Alcohol (1 = current drinker) 6.15 2.78 0.08 2.21 0.028 0.68 ~ 11.61
Smoking (1 = current smoker) 1.91 2.35 0.03 0.81 0.418 −2.71 ~ 6.53
Abbreviations: SGPT serum glutamic pyruvic transaminase, HCV hepatitis C virus, BMI body mass index, HBV hepatitis B virus
aCI: confidence interval
Dependent variable: SGPT
Model summary: F = 11.92, p < 0.001
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Moreover, 9.1 and 6.6 % of the participants reported
current and previous alcohol consumption, respectively
(Table 2). Although these habits were not directly corre-
lated with health status, previous studies have reported
that insufficient exercise, and inadequate water, fruit, and
vegetable intake were significantly associated with obesity/
overweight and HCC [20–23]. Furthermore, poor adher-
ence to a Mediterranean diet was particularly detrimental
for the risk of HCC in chronically infected HBV and/or
HCV carriers [22, 23].
The modifiable factors significantly associated with
elevated liver function included high fasting blood glu-
cose levels, overweight, and alcohol drinking in the final
regression model, in addition to HBV/HCV infection.
Similarly, a previous study indicated that important life-
style factors, such as alcohol consumption, diabetes, and
obesity, also contribute to HCC [20], and increasing evi-
dence is emerging that obesity is a major etiology for
abnormal liver function among the young generation [24].
A meta-analysis of cohort studies reported a 17 and 90 %
increased risk of HCC for overweight and obese people,
respectively, compared with those of normal weight [25].
The association between obesity and non-alcoholic fatty
liver disease could explain this increased risk [22–24]. In
addition, HBV or HCV carriers in an Aboriginal popula-
tion with a high incidence of alcohol consumption and
smoking also had the most elevated levels of biomarkers
of abnormal liver function [26].
Considering the limitations associated with physical,
mental, or multiple disabilities among this vulnerable
population, the inclusion of healthy lifestyle modifica-
tions for people with disabilities living in rural areas is
an important strategy for primary health care providers.
In addition, more convenient HBV vaccine booster pro-
grams could be provided for disabled young people
whose HBV antibodies are no longer present following
the 3 vaccination doses in infancy. Furthermore, access
to antiviral treatments at 6–12-month periods for HCV
carriers with disabilities is an important strategy for
health care providers and district governments. Moreover,
further studies are necessary to explore and initiate poten-
tial health promotion programs that encourage regular
monitoring (e.g., every 3–6 months) for the early diag-
nosis of chronic liver disease, adoption of appropriate
therapies, and avoiding overuse of alcohol and smoking
for community-dwelling adults with disabilities.
Limitations
This study had certain limitations. First, the partici-
pants were not randomly recruited and were from the
same geographic area, Chiayi County, which limits the
generalizability of these findings. Second, the descriptive
study design does not allow for causality to be established,
and possible confounders might not have been measured.
Third, self-reporting often results in underestimation of
unhealthy behaviors, such as the amount and type of
alcohol consumed and extent of cigarette smoking. Finally,
selection and recall bias need to be considered because of
the various health conditions of the participants.
Conclusions and implications
There was a high prevalence of HCV infection among
adults with disabilities in the present study; few of the
participants possessed an awareness of their liver health,
and very few received early treatment or information on
the prevention of liver cancer. Despite the presence of
some unmodifiable risk factors, early detection of un-
healthy behaviors and referral for further diagnosis of
HBV/HCV carriers, increasing awareness of virus-related
hepatitis and its consequences, providing accessible HBV
vaccine booster programs and antiviral treatments for
HCV carriers, and initiating health promotion programs
are important health strategies for these minority adults.
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